NMRA
Neumora Therapeutics, Inc.
0.4999$
-9.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
Neumora Therapeutics, Inc. (NMRA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -40 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -48 | -51 | -43 | -56 | -33 | -50 | -59 | -52 | -47 | -48 | -46 | -40 | -181 | |
| 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 6.5 | 6.1 | 7.4 | 13 | 9.9 | 9.9 | 9.3 | 7.2 | 6.0 | 7.4 | 7.4 | 7.2 | 28 | |
| -1.2 | -13 | 3.6 | -9.0 | 29 | -1.4 | -0.5 | -7.6 | 4.5 | 3.2 | -0.8 | -32 | -25 | |
| 0.0 | 0.0 | 0.8 | 0.0 | 0.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 24 | 14 | -150 | 21 | 157 | -99 | 44 | 30 | 51 | 43 | 0.1 | – | – | |
| – | – | – | – | – | – | – | – | -0.1 | 39 | – | – | – | |
| 232 | -0.5 | 1.8 | 2.7 | 1.5 | 16 | 0.0 | 18 | -0.1 | 59 | 11 | 9.3 | 79 | |
| 208 | -38 | -191 | -32 | 125 | -134 | -15 | -3.6 | 4.5 | 53 | -35 | -30 | -7.7 | |
| -48 | -51 | -43 | -56 | -33 | -50 | -59 | -52 | -47 | -48 | -46 | -40 | -181 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.